Diabetes Guidelines Update

Rancho Mirage, CA US
April 28, 2016

Jane Weinreb, MD

Chief, Endocrinology, Diabetes and Metabolism
VA Greater Los Angeles Healthcare System
Program Director for Endocrinology
UCLA-VA Greater Los Angeles Program
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
 

Target Audience

This activity was developed for physicians including Eisenhower medical staff along with nurses and ancillary staff.

Learning Objectives

At the end of this presentation, participants should be better able to:

  • Identify that metformin is first line therapy in management of type 2 diabetes and explain current FDA renal limitations to its use
  • Recognize that the choice of second line agents is based on patient preference and comorbidities
  • Contrast pro and cons of major drug classes for diabetes management, to facilitate management of diverse patients
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 Social Work
  • 1.00 CA-BRN
  • 1.00 CLS
Course opens: 
04/28/2016
Course expires: 
12/31/2016
Event starts: 
04/28/2016 - 12:00pm
Event ends: 
04/28/2016 - 1:00pm
Cost:
$0.00
Parent activity set: 
Rating: 
5
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive
Rancho Mirage, CA 92270
United States

Available Credit

  • 1.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 Social Work
  • 1.00 CA-BRN
  • 1.00 CLS

Accreditation Period

Course opens: 
04/28/2016
Course expires: 
12/31/2016

Price

Cost:
$0.00
Please login or register to take this course.